Item 1A. Risk Factors Information regarding risk factors is discussed in Item 1A, “Risk Factors” of the Company’s Annual Report on Form 10-K for the year ended December 31, 2014. There have been no material changes from the risk factors previously disclosed in the Company’s Form 10-K.40Table of ContentsItem 2. Unregistered Sales of Equity Securities and Use of Proceeds The following table sets forth the Company’s repurchases of equity securities registered under Section 12 of the Exchange Act that have occurred during the three months ended June 30, 2015:Period Totalnumberof sharespurchased Averagepricepaid pershare Total number of shares purchased as part of publiclyannounced plans or programs Maximum numberof shares that mayyet be purchasedunder the plans orprograms (c)April 2015 (April 1 – April 30) — $— — 700,000May 2015 (May 1 – May 31) 42,237(a)89.96 — 700,000June 2015 (June 1 – June 30) 1(b)84.94 — 700,000Total 42,238 $89.96 —  (a)Reflects (i) 37,556 shares repurchased from certain executive officers of the Company in privately negotiated transactions on May 12, 2015 and (ii) 4,681 shares withheld by the Company to pay taxes upon vesting of restricted stock. The Company’s Board of Directors approved the executive officer share repurchases on April 14, 2015, and the purchase price for the shares was the closing market price of the Company’s common stock as reported on the New York Stock Exchange on May 11, 2015, which was the business day prior to (i) the date of repurchase and (ii) the date on which EQGP’s IPO was priced. The following named executive officers of the Company participated in the share repurchases in the following amounts: David L. Porges (13,909 shares); Randall L. Crawford (5,842 shares); Philip P. Conti (5,564 shares); Lewis B. Gardner (5,564 shares); and Steven T. Schlotterbeck (5,564 shares). The purpose of the share repurchase was for the executive officers to use the net proceeds to purchase common units representing limited partner interests in EQGP in connection with EQGP’s IPO. No additional shares may be repurchased by the Company under the executive officer share repurchase authorization.(b)Reflects shares withheld by the Company to pay taxes upon vesting of restricted stock.(c)During 2014, the Company’s Board of Directors approved a share repurchase authorization of up to 1,000,000 shares of the Company’s outstanding common stock. The Company may repurchase shares from time to time in open market or in privately negotiated transactions. The share repurchase authorization does not obligate the Company to acquire any specific number of shares, has no pre-established end date and may be discontinued by the Company at any time. As of June 30, 2015, the Company had repurchased 300,000 shares under this authorization since its inception.41Table of ContentsItem 6. Exhibits